Immunological role of human palatine tonsil in Epstein-Barr virus persistence

Acta Oto-Laryngologica, Supplement

Volumn , Issue 523, 1996, Pages 158-160

  Hirao, Motoyasu ^a   Harabuchi, Yasuaki ^a   Kataura, Akikatsu ^a   Imai, Shosuke ^b   Osato, Toyoro ^b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cytotoxic T lymphocyte; Regression assay; Transformation

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

ADULT; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE TRANSFORMATION; PALATINE TONSIL; PHENOTYPE; PRIORITY JOURNAL; ARTICLE; B LYMPHOCYTE; CELL CULTURE; IMMUNOLOGY; IN VITRO STUDY; ISOLATION AND PURIFICATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NEWBORN; TONSIL; TONSILLITIS; VIROLOGY;

ADULT; B-LYMPHOCYTES; CELLS, CULTURED; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNITY, CELLULAR; INFANT, NEWBORN; MAJOR HISTOCOMPATIBILITY COMPLEX; T-LYMPHOCYTES, CYTOTOXIC; TONSIL; TONSILLITIS;

EID: 0029657833     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Epstein MA, Achong BG, Barr YM. Virus particles in cultured Lymphoblasts from Burkitt's lymphoma. Lancet 1964; i: 702-3.
2. Epstein MA, Achong BG. Introductory considerations. In: Epstein MA, Achong BG, eds. The Epstein-Barr virus: recent advances. London: William Heinemann Medical Books, 1986: 1-11.
3. Tosato G. The Epstein-Barr virus and the immune system. Adv Cancer Res 1987; 49: 75-125.
4. Harabuchi Y, Yamanaka N. A study of Epstein-Barr virus susceptibility in human tonsil B lymphocyte subpopulation. Jpn J Otolaryngol 1987; 90: 1799-811.
5. Lewin N, Åman P, Masucci MG, et al. Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth. Int J Cancer 1987; 39: 472-6.
6. Hirao M, Harabuchi Y, Kataura A. Studies on Epstein-Barr virus infection to the organ-cultured tonsil. Jpn J Tonsil 1992; 31: 13-17.
7. Moss DJ, Rickinson AB, Pope JH. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leucocytes. Int J Cancer 1978; 22: 662-8.
8. Wallace LE, Rickinson AB, Rowe M, Moss DJ, Allen DJ, Epstein MA. Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. I. Virus-specific and nonspecific components of the cytotoxic response. Cellular Immunol 1982; 67: 129-40.
9. Hirao M, Harabuchi Y. Analysis of Epstein-Barr virus-specific cellular immunity in tonsillar lymphocytes. Jpn J Otolaryngol 1993; 97: 473-84.
10. Wolf H, Haus M, Wilmes E. Persistence of Epstein-Barr virus in parotid gland. J Virol 1984; 51: 795-8.
11. Rickinson AB, Moss DJ, Pope JH. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leucocyte cultures. Int J Cancer 1979; 23: 610-7.
12. Misko IS, Moss DJ, Pope JH. HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. Proc Natl Acad Sci USA 1980; 77: 4247-50.